Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
The Analyst
|
January 29, 2009
Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy
A Zwielly, J Gopas, G Brkic, et al.
Journal of Ethnopharmacology
|
December 10, 2014
Anti-inflammatory effect of a Nuphar lutea partially purified leaf extract in murine models of septic shock
J Ozer, T Levi, A Golan-Goldhirsh, et al.
Israel Journal of Medical Sciences
|
February 1, 1995
CA 15-3, mucin-like carcinoma-associated antigen and tissue polypeptide-specific antigen: correlation to disease state and prognosis in breast cancer patients
A D Cohen, J Gopas, G Karplus, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels
A D Cohen, Y Shoenfeld, J Gopas, et al.
Invasion & Metastasis
|
January 1, 1991
Effect of protein kinase C activating tumor promoters on metastases formation by fibrosarcoma cells
N Isakov, J Gopas, E Priel, et al.
Immunology Letters
|
March 1, 1988
Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells
J Gopas, S Segal, G Hammerling, et al.
Ultrastructural Pathology
|
November 1, 1996
A comparison of distinct modes of tumor cell death in Hodgkin's disease using morphology and in situ DNA fragmentation
D Benharroch, I Prinsloo, J Goldstein, et al.
The Israel Medical Association Journal : IMAJ
|
September 9, 2000
Hodgkin's lymphoma in the Bedouin of southern Israel: epidemiological and clinical features
A Levy, V Diomin, J Gopas, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
March 24, 2009
Nuphar lutea: in vitro anti-leishmanial activity against Leishmania major promastigotes and amastigotes
J El-On, L Ozer, J Gopas, et al.
Transplantation
|
April 1, 1990
Failure of cell surface expression of a class I major histocompatibility antigen caused by somatic point mutation
R A Zeff, M Nakagawa, H Mashimo, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
The Analyst
|
January 29, 2009
Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy
A Zwielly, J Gopas, G Brkic, et al.
Journal of Ethnopharmacology
|
December 10, 2014
Anti-inflammatory effect of a Nuphar lutea partially purified leaf extract in murine models of septic shock
J Ozer, T Levi, A Golan-Goldhirsh, et al.
Israel Journal of Medical Sciences
|
February 1, 1995
CA 15-3, mucin-like carcinoma-associated antigen and tissue polypeptide-specific antigen: correlation to disease state and prognosis in breast cancer patients
A D Cohen, J Gopas, G Karplus, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels
A D Cohen, Y Shoenfeld, J Gopas, et al.
Invasion & Metastasis
|
January 1, 1991
Effect of protein kinase C activating tumor promoters on metastases formation by fibrosarcoma cells
N Isakov, J Gopas, E Priel, et al.
Immunology Letters
|
March 1, 1988
Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells
J Gopas, S Segal, G Hammerling, et al.
Ultrastructural Pathology
|
November 1, 1996
A comparison of distinct modes of tumor cell death in Hodgkin's disease using morphology and in situ DNA fragmentation
D Benharroch, I Prinsloo, J Goldstein, et al.
The Israel Medical Association Journal : IMAJ
|
September 9, 2000
Hodgkin's lymphoma in the Bedouin of southern Israel: epidemiological and clinical features
A Levy, V Diomin, J Gopas, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
March 24, 2009
Nuphar lutea: in vitro anti-leishmanial activity against Leishmania major promastigotes and amastigotes
J El-On, L Ozer, J Gopas, et al.
Transplantation
|
April 1, 1990
Failure of cell surface expression of a class I major histocompatibility antigen caused by somatic point mutation
R A Zeff, M Nakagawa, H Mashimo, et al.
Page
of 6